1.Extraskeletal Ewing's Sarcoma of the Hard Palate.
Mi Seon KANG ; Hye Kyoung YOON ; Jung Bae CHOI ; Jae Wook EUM
Journal of Korean Medical Science 2005;20(4):687-690
Extraskeletal Ewing's sarcoma (EES) is a rare soft tissue tumor morphologically indistinguishable from the more common Ewing's sarcoma of bone. We report a case of EES arising in the hard palate of 34-yr-old male patient. Microscopically, the monotonous small round cells without neuronal differentiation showed membranous positive immunoreactivity for MIC2/CD99 and vimentin. Ultrastructurally, the tumor cells showed a few intracytoplasmic organelles without evidence of neurosecretory granules or neurofilaments. The EWS-FLI1 chimeric gene was identified using the nested reverse transcriptase-polymerase chain reaction.
Adult
;
Antigens, CD/analysis
;
Cell Adhesion Molecules/analysis
;
Humans
;
Immunohistochemistry
;
Male
;
Oncogene Proteins, Fusion/genetics
;
Palatal Neoplasms/genetics/metabolism/*pathology
;
Palate, Hard/metabolism/*pathology
;
Proto-Oncogene Protein c-fli-1/genetics
;
Reverse Transcriptase Polymerase Chain Reaction
;
Sarcoma, Ewing's/genetics/metabolism/*pathology
;
Transcription, Genetic
;
Vimentin/analysis
2.Risk Factors for Post-ERCP Pancreatitis in Patients Pretreated with Nafamostat Mesilate.
Il Doo KIM ; Dae Hwan KANG ; Jin Hyun PARK ; Jung Ho BAE ; Pyo Jun KIM ; Yong Wook KIM ; Cheol Woong CHOI ; Jae Sup EUM ; Sun Mi LEE ; Tae Oh KIM ; Gwang Ha KIM ; Geun Am SONG
Korean Journal of Gastrointestinal Endoscopy 2008;37(4):265-270
BACKGOUND/AIMS: Pancreatitis is the most common and important complication of an endoscopic retrograde cholangiopancreatography (ERCP). The aim of this study was to identify risk factors for post ERCP-pancreatitis in patients pretreated with nafamostat mesilate, a synthetic protease inhibitor. METHODS: A total of 247 patients who underwent an ERCP were evaluated prospectively. Potential risk factors of post-ERCP pancreatitis in patients pretreated with nafamostat mesilate were evaluated. RESULTS: Twenty-four patients (9.7%) and nine patients (3.6%) developed post-ERCP hyperamylasemia and pancreatitis, respectively. As determined by univariate analysis among the potential risk factors, we found a procedure time over 20 minutes, pancreatic duct cannulation over four times, prior post-ERCP pancreatitis and the absence of a common bile duct (CBD) stone as risk factors for post-ERCP hyperamylasemia. We also found a patient age under 60 years, a procedure time over 20 minutes, pancreatic duct cannulation over four times and the absence of a CBD stone as risk factors for post-ERCP pancreatitis (p<0.05). As determined by multivariate analysis, pancreatic cannulation over four times is independently associated with post-ERCP hyperamylasemia (p=0.038; OR, 5.165; 95% CI, 1.093~24.412) and post-ERCP pancreatitis (p=0.002; OR, 33.122; 95% CI, 3.526~311.138). CONCLUSIONS: A repeated pancreatic duct cannulation is the most important risk factor for post-ERCP pancreatitis in patients pretreated with nafamostat mesilate.
Catheterization
;
Cholangiopancreatography, Endoscopic Retrograde
;
Common Bile Duct
;
Guanidines
;
Humans
;
Hyperamylasemia
;
Mesylates
;
Multivariate Analysis
;
Pancreatic Ducts
;
Pancreatitis
;
Prospective Studies
;
Protease Inhibitors
;
Risk Factors
3.Defect of Acid-base Transporters in Distal Renal Tubular Acidosis.
Hye Young KIM ; Jin Suk HAN ; Eun Sil JEON ; Ho Joon JIN ; Gwon Wook JOO ; Gee Young NA ; Woo Gyung JUNG ; Jee Eun OH ; Hyun Ree KIM ; Seo Jin LEE ; Joong Geun LEE ; Geun Ho KIM ; Jae Ho EUM ; Sung Soo GOONG ; Jin KIM ; Jung Sang LEE
Korean Journal of Nephrology 2000;19(5):899-909
The purpose of this study was to elucidate whether the molecular defect of acid-base transporters in renal tubules is related to the functional defect of urinary acidification in distal renal tubular acidosis(RTA). We performed NH4Cl, furosemide, or bicarbonate loading test to evaluate renal acidification function, and immunohistochemistry using antibodies to H+- ATPase, Cl-/HCO3- exchanger(band-3 protein), and Na+/K+-ATPase in kidney tissue in 6 patients with RTA and renal cell carcinoma patients as normal controls. Kidney tissue was obtained either by percutaneous needle biopsy(RTA) or nephrectomy(NC). The results were as follows; 1) In all six RTA patients, proton secretory defect of distal acidification was shown by a failure to lower the urine pH after NH4Cl loading or furosemide test or abnormally low urine-blood pCO2 difference during bicarbonate loading. In two patients with RTA, proximal acidification defect was combined, which was demonstrated by increased fractional excretion of bicarbonate. 2) In normal control, intense H+-ATPase and band-3 protein staining was observed in collecting ducts. 3) In distal RTA patients, H+-ATPase and band- 3 protein staining was not demonstrable or markedly decreased in the intercalated cells of distal nephron. 4) In two patients who had both proximal and distal RTA, H+-ATPase staining was markedly decreased in the brush border of proximal tubules as well as the distal nephron. In conclusion, the defect of acid-base transporters in renal tubule was related with the functional defect of urinary acidification in distal RTA.
Acidosis, Renal Tubular*
;
Adenosine Triphosphatases
;
Antibodies
;
Carcinoma, Renal Cell
;
Furosemide
;
Humans
;
Hydrogen-Ion Concentration
;
Immunohistochemistry
;
Kidney
;
Microvilli
;
Needles
;
Nephrons
;
Protons